医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Doctors Urge Massive Vaccination Campaign to Halt Rabies Scare

2013年09月03日 AM06:25
このエントリーをはてなブックマークに追加


 

WASHINGTON

Statement of Kenneth Litwak, D.V.M., Ph.D., associate director of laboratory medicine, responding to the ethics hearing that will take place in September:

“The Taiwanese Council of Agriculture (COA) plan to allow beagle puppies to be exposed to rabid ferret-badgers will not stop or prevent the spread of rabies, since rabies can infect all warm-blooded animals regardless of viral variant. Efforts must focus on stopping and preventing the spread of rabies through vaccination or there will be severe public health risk.”

“Vaccination is the most effective and expedient way to prevent the spread of rabies. Infecting dogs with rabies virus for the purpose of testing rabies vaccines efficacy is no longer considered necessary or ethical by rabies experts.”

“Current rabies vaccines protect against most rabies viruses and rabies-like viruses. The primary viral protein detected by the immune system in this new strain is over 90 percent homologous with other strains of rabies virus found in Asia. So the question is not whether the virus will spread from a ferret-badger to a dog, which is what the COA is proposing to test, and is already known. The question is how well can current vaccinations protect against this new viral strain. This can be addressed quickly with current in vitro methods, such as virus neutralization assays.”

“To stem the rabies outbreak, the COA must focus on wide spread vaccination efforts and stop wasting valuable time, effort, and money on experiments that will only continue to prove that rabies can spread from animal to animal and animal to human – we know this.”

“Sept. 28 is World Rabies Day. For Taiwan to avert this potential public health crisis, the government needs to adopt an aggressive rabies vaccination campaign to ask all citizens of Taiwan to vaccinate their dogs and other animals by World Rabies Day.”

For more information or to interview Dr. Litwak, please contact Jeanne McVey at 202-527-7316 or JMcvey@pcrm.org.

CONTACT

Physicians Committee for Responsible Medicine (PCRM)
Jeanne McVey,
+1-202-427-9300
jeannem@pcrm.org

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表